An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials
Journal of Nanobiotechnology, ISSN: 1477-3155, Vol: 14, Issue: 1, Page: 16
2016
- 123Citations
- 106Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations123
- Citation Indexes118
- 118
- CrossRef63
- Policy Citations5
- 5
- Captures106
- Readers106
- 106
Article Description
Background: Most in vitro studies investigating nanomaterial pulmonary toxicity poorly correlate to in vivo inhalation studies. Alveolar macrophages (AMs) play an outstanding role during inhalation exposure since they effectively clear the alveoli from particles. This study addresses the applicability of an in vitro alveolar macrophage assay to distinguish biologically active from passive nanomaterials. Methods: Rat NR8383 alveolar macrophages were exposed to 18 inorganic nanomaterials, covering AlOOH, BaSO, CeO, FeO, TiO, ZrO, and ZnO NMs, amorphous SiO and graphite nanoplatelets, and two nanosized organic pigments. ZrO and amorphous SiO were tested without and with surface functionalization. Non-nanosized quartz DQ12 and corundum were used as positive and negative controls, respectively. The test materials were incubated with the cells in protein-free culture medium. Lactate dehydrogenase, glucuronidase, and tumour necrosis factor alpha were assessed after 16 h. In parallel, HO was assessed after 1.5 h. Using the no-observed-adverse-effect concentrations (NOAECs) from available rat short-term inhalation studies (STIS), the test materials were categorized as active (NOAEC < 10 mg/m) or passive. Results: In vitro data reflected the STIS categorization if a particle surface area-based threshold of <6000 mm/mL was used to determine the biological relevance of the lowest observed significant in vitro effects. Significant effects that were recorded above this threshold were assessed as resulting from test material-unspecific cellular 'overload'. Test materials were assessed as active if ≥2 of the 4 in vitro parameters undercut this threshold. They were assessed as passive if 0 or 1 parameter was altered. An overall assay accuracy of 95 % was achieved. Conclusions: The in vitro NR8383 alveolar macrophage assay allows distinguishing active from passive nanomaterials. Thereby, it allows determining whether in vivo short-term inhalation testing is necessary for hazard assessment. Results may also be used to group nanomaterials by biological activity. Further work should aim at validating the assay.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84962127805&origin=inward; http://dx.doi.org/10.1186/s12951-016-0164-2; http://www.ncbi.nlm.nih.gov/pubmed/26944705; http://www.jnanobiotechnology.com/content/14/1/16; https://facultyopinions.com/prime/726308813#eval793517325; http://dx.doi.org/10.3410/f.726308813.793517325; https://dx.doi.org/10.1186/s12951-016-0164-2; https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-016-0164-2; https://jnanobiotechnology.biomedcentral.com/counter/pdf/10.1186/s12951-016-0164-2; http://f1000.com/prime/726308813#eval793517325; http://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-016-0164-2
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know